Living situation, social network and outcome in schizophrenia: a five-year prospective follow-up study

Acta Psychiatrica Scandinavica
Raimo K R Salokangas

Abstract

A representative sample of 227 first-contact schizophrenic patients (according to DSM-III) was followed up for 5 years. The psychiatric teams responsible for the treatment of the patients conducted detailed standardized interviews with the patients at entry and at the end of the first, second and fifth years. Changes in patients' clinical and functional outcome were analysed according to their living situation and social network. Positive changes in clinical state and functional ability were most prominent among patients who were living with their spouse. The social and functional outcome of men living with their parents was better than that of women in the same situation, while among patients living alone or with some other person the gender difference was reversed. Family environment can be of great importance to schizophrenic patients, supporting their clinical and functional recovery from psychosis. Patients living outside families--and men in particular--are at great risk of poor outcome, perhaps because they often lose their social contacts. In the treatment of such individuals a more active strategy of out-patient and rehabilitative care is therefore needed.

References

Jan 1, 1978·Acta Psychiatrica Scandinavica. Supplementum·M AsbergG Sedvall
Jan 1, 1978·Schizophrenia Bulletin·C I Cohen, J Sokolovsky
Jan 1, 1978·Schizophrenia Bulletin·N SartoriusR Shapiro
Dec 1, 1976·Family Process·C C Tolsdorf
Jan 1, 1975·Schizophrenia Bulletin·M J Goldstein, E H Rodnick
Oct 1, 1990·Schizophrenia Research·R K Salokangas, E Stengård
Jan 1, 1989·Schizophrenia Bulletin·N G HamiltonR M Weigel
May 1, 1989·Psychological Medicine·M C AngermeyerL Kuehn
Jun 1, 1986·Acta Psychiatrica Scandinavica·M V Seeman
Mar 1, 1989·The American Journal of Psychiatry·G D Erickson
Jan 1, 1986·Monographien aus dem Gesamtgebiete der Psychiatrie·Y O AlanenA Kaljonen
Nov 1, 1986·Acta Psychiatrica Scandinavica·R K Salokangas
Aug 1, 1984·The American Journal of Psychiatry·A Breier, J S Strauss
Feb 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·R K Salokangas
Mar 1, 1958·British Journal of Urology·J HELLSTROMC A EDVALL

❮ Previous
Next ❯

Citations

Mar 3, 2005·Social Psychiatry and Psychiatric Epidemiology·Jyrki KorkeilaHasse Karlsson
May 24, 2007·Social Psychiatry and Psychiatric Epidemiology·Amy M KilbourneFrederic C Blow
Jun 29, 2007·Social Psychiatry and Psychiatric Epidemiology·Georg SchomerusUNKNOWN European Schizophrenia Cohort
Jun 19, 2008·Social Psychiatry and Psychiatric Epidemiology·Helen FisherSonia Johnson
Nov 28, 2008·Social Psychiatry and Psychiatric Epidemiology·Aileen O'BrienSwaran P Singh
Jan 28, 2005·Community Mental Health Journal·Patrick W Corrigan, Sean M Phelan
Jun 25, 2005·Community Mental Health Journal·Alexander S YoungPaul Koegel
Jul 3, 2013·Psychiatry Research·Luis H RipollAntonia S New
Feb 19, 2004·Epidemiologia e psichiatria sociale·Juan Eduardo Tello, Paola Bonizzato
Jul 27, 2012·Epidemiology and Psychiatric Sciences·C Gayer-Anderson, C Morgan
Nov 25, 2003·Psychiatry and Clinical Neurosciences·Yuriko SuzukiKoichi Otani
Jul 11, 2006·Psychiatry·William P HoranKeith H Nuechterlein
Jun 22, 2006·European Archives of Psychiatry and Clinical Neuroscience·Angelo PicardiPierluigi Morosini
Oct 1, 2005·International Review of Psychiatry·Helen Herrman, Carol Harvey
Nov 5, 2010·International Review of Psychiatry·Kathryn M AbelJill M Goldstein
Jul 27, 2012·Schizophrenia Research·Ross M G NormanSandra Northcott
Mar 5, 2016·Journal of Immigrant and Minority Health·Alejandra Caqueo-UrízarStephen E Gilman
Nov 30, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·E LauronenM Isohanni
Aug 25, 2004·Journal of Advanced Nursing·Johannes JungbauerMatthias C Angermeyer
Jul 12, 2005·Psychology and Psychotherapy·R HirschfeldC Griffin
Mar 18, 2006·Acta Psychiatrica Scandinavica. Supplementum·R WilliamsR Balshaw
Jun 30, 2009·Schizophrenia Research·Rebecca Schennach-WolffMichael Riedel
Mar 17, 2012·Psychiatry Research·Ilja SpellmannHans-Jürgen Möller
Feb 15, 2014·Social Science & Medicine·Brea L Perry, Bernice A Pescosolido
Oct 9, 2002·Acta Psychiatrica Scandinavica·J UsallUNKNOWN Needs of Patients with Schizophrenia group
May 31, 2001·Acta Psychiatrica Scandinavica·L A AuslanderD V Jeste
Dec 7, 2011·Journal of Health and Social Behavior·Brea L Perry
Feb 5, 2005·São Paulo Medical Journal = Revista Paulista De Medicina·Alexandre Duarte Gigante, Saulo Castel
Jun 8, 2017·The International Journal of Social Psychiatry·Bernadette Am CullenWilliam W Eaton
Oct 29, 2005·The International Journal of Social Psychiatry·Janis H JenkinsMartha Sajatovic
Jan 10, 2008·The International Journal of Social Psychiatry·Brigitte MüllerWulf Rössler
Sep 27, 2003·The Australian and New Zealand Journal of Psychiatry·A R MubarakQuah Soon Hoe
Oct 27, 2017·The International Journal of Social Psychiatry·Jitske F KoendersMartijn Kikkert
May 31, 2018·The International Journal of Social Psychiatry·Antonio J Vázquez MorejónRaquel Vázquez-Morejón
Feb 1, 2013·Clinical Schizophrenia & Related Psychoses·Margareta Östman, Ann-Christine Björkman
Nov 20, 2013·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Emanuela TerzianUNKNOWN SIRS (Studio di Intervento sulla Rete Sociale [Social Network Intervention Study]) Collaborative Study Group
Jun 15, 2006·Culture, Medicine and Psychiatry·Janis H Jenkins, Elizabeth Carpenter-Song
Feb 16, 2021·Frontiers in Psychiatry·Bernice C van AkenCornelis L Mulder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.